<DOC>
	<DOCNO>NCT03016650</DOCNO>
	<brief_summary>The investigator aim evaluate tramadol-sparing effect intravenous ( IV ) ibuprofen patient undergo percutaneous nephrolithotomy ( PCNL ) .</brief_summary>
	<brief_title>Opioid-sparing Effect Intravenous Ibuprofen</brief_title>
	<detailed_description>Eighty patient undergo PCNL randomize intravenous paracetamol ( n=40 ) intravenous ibuprofen ( n=40 ) group . Patients receive 100 mL physiologic saline 1 g IV paracetamol 800 mg IV ibuprofen 30 minute end operation postoperatively 6 , 12 18 hour PCNL paracetamol ibuprofen group , respectively . Patients group receive intravenous tramadol patient control analgesia device ( PCA ) . The visual analog scale ( VAS ) use evaluate pain intensity score postoperative period . Total tramadol consumption , mean VAS score 1 , 8 24 hour , demographic variable , operative variable , side effect record .</detailed_description>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Study include 80 patient American Society Anesthesiologists ( ASA ) physical status III age 1870 year schedule percutaneous nephrolithotomy operation . chronic pain , psychiatric disease , renal dysfunction , allergy nonsteroidal antiinflammatory drug , history drug addiction , pregnancy , inability use patient control analgesia ( PCA ) device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Acetaminophen</keyword>
	<keyword>Ibuprofen</keyword>
</DOC>